C. Chow

Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers

L. Chow, Cheng-Hsun Wu, C. Chow, 2022, Frontiers in Oncology.

Epigenetic Changes of TIMP-3, GSTP-1 and 14-3-3 Sigma Genes as Indication of Status of Chronic Inflammation and Cancer

L. Chow, W. Loo, Ling He, 2014, The International journal of biological markers.

New Developments in Breast Cancer Prognosis: Molecular Predictors of Treatment Response and Survival

L. Chow, W. Loo, M. Boost, 2013, The International journal of biological markers.

Neoadjuvant palbociclib on ER+ breast cancer (N007): clinical response and EndoPredict’s value

S. Morita, M. Toi, L. Chow, 2017, Endocrine-related cancer.

Association of Cytokines, High Sensitive C-Reactive Protein, VEGF and Beta-Defensin-1 Gene Polymorphisms and Their Protein Expressions with Chronic Periodontitis in the Chinese Population

L. Chow, W. Loo, Min Wang, 2013, The International journal of biological markers.

Outcomes of Adjuvant Endocrine Therapy and Hormone Receptor Status Change following Neoadjuvant Chemotherapy in Breast Cancer Patients

L. Chow, W. Loo, K. Shen, 2014, The International journal of biological markers.

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients

A. Leo, M. Toi, L. Biganzoli, 2017, Asia-Pacific journal of clinical oncology.

Salivary biomarkers to monitor osteopenia and stress levels in breast cancer survivors

L. Chow, W. Loo, Min Wang, 2017 .